Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Genomics02:02

Genomics

35.5K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
35.5K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

7.8K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.8K
Genetic Screens02:46

Genetic Screens

4.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.6K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

12.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.6K
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

253
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
253
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Short-Read Sequencing Benchmarking with Donor-Specific Assemblies.

bioRxiv : the preprint server for biology·2026
Same author

Structural variant discovery and diagnostic impact in rare diseases from short-read and long-read sequencing.

medRxiv : the preprint server for health sciences·2026
Same author

Publisher Correction: Interplay between cohesin and RNA polymerase II in regulating chromatin interactions and gene transcription.

Nature structural & molecular biology·2026
Same author

Determinants of haplotype phasing accuracy in long-read human genome sequencing.

bioRxiv : the preprint server for biology·2026
Same author

Harmonizing standards and resources for the medical genome.

Nature·2026
Same author

Evolutionary dynamics of Respiratory Syncytial Virus in pre-pandemic, pandemic, and post-pandemic periods in Houston, Texas, USA.

bioRxiv : the preprint server for biology·2026
Same journal

Daily briefing: 'Cyborg' cockroaches breathe underwater with printed suit.

Nature·2026
Same journal

China boosts prestigious grants for young scientists - will it ease competition?

Nature·2026
Same journal

Incoming US science academy chief vows to 'double down' on research.

Nature·2026
Same journal

Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

Nature·2026
Same journal

Electrodeposited self-assembled molecules for perovskite photovoltaics.

Nature·2026
Same journal

Neutrino's nursery found: the 'Shadow Blaster'.

Nature·2026
関連記事をすべて見る

関連する実験動画

Updated: May 3, 2026

iCLIP - Transcriptome-wide Mapping of Protein-RNA Interactions with Individual Nucleotide Resolution
10:45

iCLIP - Transcriptome-wide Mapping of Protein-RNA Interactions with Individual Nucleotide Resolution

Published on: April 30, 2011

59.3K

GREGoR:希少疾患のゲノミクスを加速する

Moez Dawood1,2,3, Ben Heavner4, Marsha M Wheeler4

  • 1Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA. mdawood@bcm.edu.

Nature
|November 12, 2025
PubMed
まとめ
この要約は機械生成です。

希少疾患の遺伝学を解明するためのゲノミクス研究 (GREGoR) コンソーシアムは,ゲノミクス技術の適用と標準化により,希少疾患の診断を加速します. このイニシアチブは,未解決の希少疾患の遺伝子診断を進めるために重要なデータセットを提供します.

さらに関連する動画

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery
07:43

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery

Published on: August 23, 2016

10.4K
Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition
08:38

Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition

Published on: July 21, 2023

1.6K

関連する実験動画

Last Updated: May 3, 2026

iCLIP - Transcriptome-wide Mapping of Protein-RNA Interactions with Individual Nucleotide Resolution
10:45

iCLIP - Transcriptome-wide Mapping of Protein-RNA Interactions with Individual Nucleotide Resolution

Published on: April 30, 2011

59.3K
An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery
07:43

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery

Published on: August 23, 2016

10.4K
Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition
08:38

Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition

Published on: July 21, 2023

1.6K

科学分野:

  • ゲノミクス
  • 珍しい 病気
  • 医学 遺伝学

背景:

  • 希少疾患は世界で約20人に1人に罹患し,診断に重大な課題をもたらします.
  • 次世代のシーケンシングの進歩にもかかわらず 疑われる希少疾患の症例の半分以上が 未診断のままです
  • 既存の臨床遺伝子検査では 珍しい疾患の患者で 原因となる遺伝的変異を 特定することができないことが多いのです

研究 の 目的:

  • 難しい珍しい病気の症例を研究するための協力的枠組みを確立する.
  • 珍しい病気の診断のための新興ゲノミクス技術を適用し,標準化し,評価する.
  • 希少疾患に対する先進的なゲノム学的アプローチの臨床採用を加速する.

主な方法:

  • 希少疾患の遺伝学を解明するゲノム研究コンソーシアム (GREGoR) は,何千もの希少疾患の症例と家族を研究した.
  • 先進的なゲノミクス技術と 計算分析を用いて 遺伝子と変種を優先順位付けました
  • 分析・ビジュアライゼーション・インフォマティクス・ラボ・スペース (AnVIL) を通じて,広範な臨床・遺伝子データを利用可能にした.

主要な成果:

  • 3千の家族から 7,500人を超える ゲノムデータを集めた
  • これまでに解明されていない 珍しい病気の潜在的な遺伝子診断を特定しました
  • 希少疾患のゲノム研究のための基礎リソースを確立しました.

結論:

  • GREGoRコンソーシアムは 希少疾患の診断を進めるために 重要なリソースとデータセットを提供しています
  • ゲノミクス技術とデータ共有の標準化が 難しい稀有病の解決の鍵となります
  • このイニシアチブは 希少疾患の遺伝子診断を改善するための 世界的な取り組みを促しています